Shanghai Rjtpharma Technology Co., LTD., located in The Medical Park of Shanghai Zhangjiang High-tech Park, was established in May 2020 with a registered capital of 5 million yuan. As a CRO company, it is committed to providing a series of professional technical services, such as new drug research, generic drug consistency evaluation research, pharmaceutical intermediates sales and so on. With more than 30 employees and a laboratory area of 2000 square meters, the company has the capability of chemical synthesis, separation and preparation research and development, providing consistent and intimate quality for the company's customers. The company has cooperative pilot workshop and GMP workshop.
The company's main business includes pharmaceutical chemical raw materials and intermediates sales, pharmaceutical impurities separation and preparation, pharmaceutical API and intermediates custom synthesis, drug consistency evaluation of raw materials and preparation research, drug reference procurement services, etc.
Has developed varieties including Rivaroxaban and intermediates, tenofovir and intermediates, Fluralaner and intermediates, oseltamivir phosphate and intermediates,Avibactam Sodium and intermediates Dopamine hydrochloride and intermediates and so on more than 30 varieties.
Company established time
Number of employees
Warehouse scale
ProName: 3,4-Dimethoxyphenylacetonitrile
CAS: 93-17-4
Capacity:
